HIV incidence among injection drug users in New York City, 1990 to 2002: Use of serologic test algorithm to assess expansion of HIV prevention services

American Journal of Public Health

Volumn 95, Issue 8, 2005, Pages 1439-1444

  Des Jarlais, Don C ^a   Perlis, Theresa ^b   Arasteh, Kamyar ^b   Torian, Lucia V ^b   Beatrice, Sara ^b   Milliken, Judith ^b   Mildvan, Donna ^b   Yancovitz, Stanley ^b   Friedman, Samuel R ^b  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ALGORITHM; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HEALTH CARE UTILIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFANT; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NEWBORN; PUBLIC HEALTH SERVICE; SEROCONVERSION; SEROLOGY; SYRINGE;

ADULT; AIDS SERODIAGNOSIS; ALGORITHMS; COMMUNITY HEALTH SERVICES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH CARE SURVEYS; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; NEEDLE-EXCHANGE PROGRAMS; NEW YORK CITY; PREVENTIVE HEALTH SERVICES; RISK REDUCTION BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 23044510831     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.2003.036517     Document Type: Article

References (25)

1. Janssen R, Statten G, Stramer S, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA. 1998;280(1):42-48.
2. Karon J, Kaplan EH, Brookmeyer R, Song R. Proposals for estimating HIV incidence in the United States from HIV reporting data and the detuned assay. Paper presented at: XIV International AIDS Conference; July 7-12, 2002; Barcelona, Spain.
3. Rawal B, Janssen R, Hecht F, Busch M. Development of less-sensitive anti-HIV-1 EIA to detect early HIV-1 infection using 96-well-formatted HIV-1 EIA kits. Paper presented at: 7th Conference on Retroviruses and Opportunistic Infections; January 30-February 2, 2000; San Francisco, Calif.
4. Kral AH, Lorvick J, Gee L, et al. Trends in human immunodeficiency virus seroincidence among street-recruited injection drug users in San Francisco, 1987-1998. Am J Epidemiol. 2003;157(10):915-922.
5. McFarland W, Busch MP, Kellogg TA, Rawal BD, Satten GA, Katz MH. Detection of early HIV infection and estimation of HIV incidence using sensitive/less sensitive testing strategy at anonymous counseling and testing sites in San Francisco. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;22:484-489.
6. Des Jarlais DC, Friedman SR, Novick D, et al. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA. 1989;261:1008-1012.
7. Des Jarlais DC, Friedman SR, Sotheran JL, et al. Continuity and change within an HIV epidemic: injecting drug users in New York City, 1984 through 1992. JAMA. 1994;271(2):121-127.
8. Des Jarlais DC. The state of syringe exchange in the known universe. Paper presented at: 12th North American Syringe Exchange Convention; April 2002; Albuquerque, NM.
9. HIV Seroprevalence, Semiannual Report. Albany: New York State Dept of Health; 1992.
10. Des Jarlais DC, Marmor M, Friedmann P, et al. HIV incidence among injecting drug users in New York City, 1992-1997: evidence for a declining epidemic. Am J Public Health. 2000;90(3):352-359.
11. Des Jarlais DC, Perlis T, Friedman SR, et al. Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997 Am J Public Health. 2000;90(7):1112-1116.
12. Maslow CB, Friedman SR, Perils TE, Rockwell R, Des Jarlais DC. Changes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990-1999. Am J Public Health. 2002;92(3): 382-384.
13. Parekh B, Dobbs T, Pau CP, et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses. 2002;18(4):295-307.
14. Friedman SR, Jose B, Deren S, Des Jarlais DC, Neaigus A. Risk factors for HIV seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. Am J Epidemiol. 1995;142:864-874.
15. Des Jarlais DC, Friedman SR, Marmor M, et al. Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug users. AIDS. 1987;1:105-111.
16. Hartel DM, Schoenbaum EE. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Public Health Rep. 1998;113(suppl 1):107-115.
17. Holmberg S. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health. 1996;86(5):642-654.
18. Des Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996;348: 987-991.
19. Des Jarlais DC, Diaz R, Perlis T, et al. Variability in the incidence of HIV, HBV, and HCV infection among young injecting drug users in New York City. Am J Epidemiol. 2003;157(5):467-471.
20. HIV Surveillance and Epidemiology Program, HIV Incidence in New York City, 2001: Estimates Using the Serologic Testing Algorithm for Recent HIV Seroconversion. New York City: Dept of Health and Mental Hygiene; 2003.
21. National Commission on AIDS. Full Report: The Twin Epidemics of Substance Use and HIV. Washington, DC: US National Commission on AIDS; July 1991.
22. Interventions to Prevent HIV Risk Behaviors, National Institutes of Health. Consensus Statement Online February 11-13, 1997; 15(2):1-41. Available at http://www.consensus.nih.gov/cons/104/104_statement.htm. Accessed May 27, 2005.
23. Normand J, Vlahov D, Moses LE, eds. Preventing HIV Transmission: The Role of Sterile Needles and Bleach. Washington, DC: National Academy Press/National Research Council/Institute of Medicine; 1995.
24. The Cochrane Collaborative Review Group on HIV Infection and AIDS. Evidence assessment: strategies for HIV/AIDS prevention, treatment and care. San Francisco, Calif: University of California, San Francisco, Institute for Global Health; 2004. Available at: http://www.igh.org/Cochrane/pdfs/ EvidenceAssessment.pdf. Accessed May 27, 2005.
25. Des Jarlais DC, Perlis T, Arasteh K, et al. "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001. J Acquir Immune Defic Syndr. 2004;35(2):158-166.